This is a preview. Log in through your library . Abstract Metastatic osteosarcoma has a poor prognosis with a 2-y, event-free survival rate of ∼15 to 20%, highlighting the need for the advancement of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback